Lupin receives warning letter from USFDA for its Somerset facility
On June 13, the drug maker Lupin received a warning letter from the USFDA for the company’s Somerset facility in…
On June 13, the drug maker Lupin received a warning letter from the USFDA for the company’s Somerset facility in…